|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.50 ARS | 0.00% |
|
0.00% | -33.26% |
| Market Cap | 6.84B 4.76M 4.11M 3.78M 3.55M 6.68M 449M 6.73M 44.74M 17.42M 220M 17.87M 17.48M 763M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.57B 5.27M 4.55M 4.18M 3.94M 7.4M 498M 7.46M 49.57M 19.3M 244M 19.79M 19.37M 845M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -3.60% | ||
| 3 months | -13.94% | ||
| 6 months | -25.69% | ||
| Current year | -33.26% |
| 1 week | 160 | 169.5 | |
| 1 month | 155 | 176.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -57.76% | +669.78% | 4.77M | ||
| +0.02% | -2.13% | -50.79% | -52.90% | 33.26B | ||
| +0.58% | +6.34% | +78.69% | +137.73% | 12.1B | ||
| +0.41% | -3.82% | +1.97% | +23.83% | 4.46B | ||
| -1.48% | -3.07% | +4.73% | +16.29% | 3.28B | ||
| -3.88% | -0.58% | +56.79% | +23.70% | 2B | ||
| -3.16% | +5.88% | -24.29% | +2.27% | 1.78B | ||
| +0.08% | +2.05% | +30.14% | +127.77% | 1.29B | ||
| -2.30% | -0.33% | -24.03% | -12.27% | 1.05B | ||
| -3.31% | -2.13% | -8.14% | -47.25% | 1B | ||
| Average | -1.29% | +0.03% | +0.73% | +88.90% | 6.02B | |
| Weighted average by Cap. | -0.23% | -2.12% | -10.58% | +3.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.76M 4.97M 4.57M 4.3M 8.08M 544M 8.15M 54.16M 21.09M 267M 21.63M 21.17M 923M | 6.4B 4.46M 3.85M 3.54M 3.33M 6.26M 421M 6.31M 41.91M 16.32M 207M 16.74M 16.38M 715M |
| Net income | -1.42B -987K -851K -783K -737K -1.38M -93.15M -1.4M -9.28M -3.61M -45.71M -3.7M -3.63M -158M | -4.6B -3.2M -2.76M -2.54M -2.39M -4.49M -302M -4.53M -30.09M -11.72M -148M -12.02M -11.76M -513M |
| Net Debt | 863M 601K 519K 477K 449K 843K 56.73M 850K 5.65M 2.2M 27.84M 2.26M 2.21M 96.31M | 738M 514K 443K 407K 384K 721K 48.48M 727K 4.83M 1.88M 23.8M 1.93M 1.89M 82.32M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 160.50 $ | 0.00% | 16,450 |
| 12/06/26 | 160.50 $ | -0.62% | 4,200 |
| 11/06/26 | 161.50 $ | 0.00% | 9,352 |
| 10/06/26 | 161.50 $ | +0.62% | 11,082 |
| 09/06/26 | 160.50 $ | +0.31% | 12,579 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















